Latest news

An Instituto Bernabeu study analyses if ovarian stimulation can alter the risk of aneuploidies and mosaicism in embryos

  • 12/05/19

The aim of research work performed by the Genetics and Molecular Biology Department at Instituto Bernabeu IBBiotech was to determine if there is a relationship between the ovarian stimulation process in cycles of in vitro fertilisation (IVF) and the aneuploidy and mosaicism rate in embryos. The conclusions were presented at the Association for the Study of Reproduction Biology (ASEBIR) Congress held in October in Cáceres.

Read more

An Instituto Bernabeu research project demonstrates that the aneuploidy and mosaicism rates in blastocysts is similar in vitrified oocytes and fresh oocytes

  • 12/03/19

Instituto Bernabeu gave an oral communication about oocyte vitrification at the Association for the Study of Reproduction Biology (ASEBIR) Congress held in Cáceres in October. Freezing is common practice during in vitro fertilisation (IVF) treatment because it increases the available number of blastocysts for analysis.

Read more

Instituto Bernabeu obtains the QH* Excellence in Healthcare accreditation

  • 11/28/19

Instituto Bernabeu’s strive for excellence is clearly marked out in a meticulous work method and implementation of the most demanding healthcare and process quality controls with the aim of always achieving excellent results. The healthcare that patients are given is endorsed by certifications and accreditations awarded to the clinic by independent entities. Instituto Bernabeu Group has recently been awarded the QH* accreditation. It entails not only a renewal of the Quality Healthcare (QH) certification, but also an additional, higher level that has been driven by the ‘increase in the validity of certain certifications’, as highlighted by the Institute for Development and Integration of Health (IDIS), the accrediting organism.

Read more

Merck features Instituto Bernabeu research work on the efficiency of double stimulation as presented at the ESHRE congress

  • 11/27/19

Instituto Bernabeu gave an oral communication at the European Society of Human Reproduction and Embryology (ESHRE) Congress entitled ‘The luteal phase of double ovarian stimulation treatment (DuoStim) provides higher oocyte and blastocyst yield in unselected infertile patients: a retrospective, same-patient, cohort study.’ This study is included in the articles that Merck has featured in its specialist journal focussing on fitting publications that is released following the scientific gathering focussing on fitting publications.

Read more

Instituto Bernabeu studies if mosaic segmental aneuploidy embryos affect pregnancy rates

  • 11/25/19

Instituto Bernabeu attended the Association for the Study of Reproduction Biology (ASEBIR) Congress held in Cáceres and presented a study about the effect that segmental chromosomal aneuploidies have on the embryo.

Read more

Nine pieces of Instituto Bernabeu research work at the Association for the Study of Reproduction Biology (ASEBIR) Congress held in Cáceres

  • 11/21/19

Once again this year, Instituto Bernabeu attended the Association for the Study of Reproduction Biology (ASEBIR) Congress. It was held in Cáceres from 23rd to 25th October 2019. Nine items of research work performed by the Embryology Unit and the Molecular Biology and Genetics Department were presented at the national congress. It is the most significant congress of its kind in the field of reproduction biology.

Read more

Instituto Bernabeu presents its pioneering research on the impact of assisted reproduction treatment at the microbiome congress in Milan

  • 11/13/19

Instituto Bernabeu attended the World of Microbiome Pregnancy, Birth and Infancy congress held in Milan, Italy from 31st October to 2nd November. Dr Belén Lledó, Scientific Director of IBBiotech presented Instituto Bernabeu’s pioneering research into the impact of the vaginal microbiome on the results of assisted reproduction treatment.

Read more

Endometrial receptivity workshop moderated by Dr Llácer during the clinical gathering about reproduction organised by Ferring in Valencia

  • 11/12/19

Dr Joaquín Llácer, Medical Co-Director of Instituto Bernabeu, moderated the Endometrial Receptivity Workshop held within the framework of the 4th Clinical Workshops on Reproduction Medicine organised by Ferring and held in Valencia on 8th and 9th November.

Read more

Instituto Bernabeu researches the effectiveness of beginning ovarian stimulation protocols in ova donors irrespective of the stage of the menstrual cycle

  • 10/30/19

Instituto Bernabeu has submitted a pilot study involving ova donors to the European Society of Human Reproduction and Embryology (ESHRE). It researches differences in results when conventional ovarian stimulation protocols are applied in comparison with new, no fixed time stimulation protocols that do not take the stage of the menstrual cycle into account. The research entailed an analysis of ova donation cycles which was performed over ten months. It compared stimulation beginning on days 1 to 3 with ovarian stimulation that had no fixed time from day 4 onwards.

Read more

The Rafael Bernabeu Social Welfare Foundation has awarded 10,000 euros to four Medicine and Biotechnology students who have limited financial resources

  • 10/29/19

The Rafael Bernabeu Social Welfare Foundation has published the results of the 2018-2019 scholarships awards. The scholarships provide Medicine, Nursing, Biology and Biotechnology students in Spain with financial support in order boost their studies. On this occasion, further to assessment of all the applications that were received, the Awards Committee chose to award four students the scholarships worth a total of 10,000 euros. 

Read more

Do you need help? 
We can help you with a no-obligation